Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.
Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check8 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check37 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference1%
- Check58 days agoChange DetectedThe website has added new features, while several detailed options for data download and participant information have been removed.SummaryDifference2%
- Check73 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.